Clinical Study of Low Molecular Weight Heparin Combined with Salmeterol Xinafoate and Fluticasone Propionate Inhalation in the Treatment of Chronic Obstructive Pulmonary Disease in Stable Stage with Pulmonary Hypertension

YE Weijie; GAO Yanchao; LU Haonan; HUANG Xuefen; ZHUO Yufeng

doi:10.14033/j.cnki.cfmr.2022.03.006

Home>Articles>Clinical Study of Low Molecular Weight Heparin Combined with Salmeterol Xinafoate and Fluticasone Propionate Inhalation in the Treatment of Chronic Obstructive Pulmonary Disease in Stable Stage with Pulmonary Hypertension

DOI: 10.14033/j.cnki.cfmr.2022.03.006

Clinical Study of Low Molecular Weight Heparin Combined with Salmeterol Xinafoate and Fluticasone Propionate Inhalation in the Treatment of Chronic Obstructive Pulmonary Disease in Stable Stage with Pulmonary Hypertension

YE Weijie

GAO Yanchao

LU Haonan

HUANG Xuefen

ZHUO Yufeng

Machine-generated Keywords：

Publication Date：2022-01-25

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 23-26 )

Chinese and Foreign Medical Research

ISSN：1674-6805

Year, Vol.(Issue)：2022,20(3)